Weiermayer P, Frass M, Peinbauer T, Ellinger L
Tierärztin, Tierarztpraxis Dr. Weiermayer, Diplom der Europ. Akademie für Veterinärhomöopathie (EAVH), Fachtierärztin für Homöopathie, Sprecherin der Sektion Forschung der Wissensch. Gesellsch. für Homöopathie (WissHom), Präsidentin ÖGVH, Wien, Österreich.
Facharzt für Innere Medizin und Internistische Intensivmedizin, em. Professor für Innere Medizin der Medizinischen Universität Wien, Diplom der Österreichischen Ärztekammer (ÖÄK) für Homöopathie sowie für Begleitende Krebsbehandlung, Wien, Österreich.
Schweiz Arch Tierheilkd. 2020 Oct;162(10):597-615. doi: 10.17236/sat00273.
The basic principles of homeopathy, and its legal and scientific foundations, are discussed in an overview to address the positions of the World Health Organization (WHO) and the commission of the European Union (EU) on complementary medicine. According to the WHO, the antimicrobial resistance problem poses a global threat. The EU Commission's current One Health Action Plan requests research in complementary medicine, the WHO urges member states to include complementary medicine in their national health policies. Regarding external evidence on the general use of human and veterinary homeopathy, evidence level 1a studies are reviewed. Focusing on the external evidence on the use of homeopathy in infections, some evidence level 1a, 1b, 2c studies, and a case report, are described in more detail. In conclusion, evidence for the effectiveness of human and veterinary homeopathy in general, and in particular, of homeopathic treatment for infections, is available. Especially, individualized homeopathy demonstrates effects at all quality levels according to Cochrane criteria, even in the methodologically high-quality studies. As in most areas of veterinary medicine and medicine, further good/excellent studies are necessary. In compliance with the principles of homeopathy, further methodologically high-quality trials focusing on the homeopathic treatment of infections are the next logical step. The selection of the simile (individually fitting homeopathic medicinal product) by appropriately trained homeopathic doctors/veterinarians is essential for the effectiveness of homeopathy. Implementation of studies at university facilities is a prerequisite for quality assurance. Consequently, further integration of homeopathy at universities is a necessary requirement for the patients' best interests.
顺势疗法的基本原理及其法律和科学基础在一篇综述中进行了讨论,以阐述世界卫生组织(WHO)和欧盟(EU)委员会在补充医学方面的立场。根据WHO的说法,抗菌药物耐药性问题构成了全球威胁。欧盟委员会当前的“同一个健康”行动计划要求对补充医学进行研究,WHO敦促成员国将补充医学纳入其国家卫生政策。关于人类和兽医顺势疗法一般用途的外部证据,对1a级证据水平的研究进行了综述。重点关注顺势疗法在感染治疗中应用的外部证据,对一些1a级、1b级、2c级证据水平的研究以及一份病例报告进行了更详细的描述。总之,有证据表明人类和兽医顺势疗法总体上是有效的,特别是顺势疗法对感染的治疗是有效的。尤其是,根据Cochrane标准,个体化顺势疗法在所有质量水平上都显示出效果,即使在方法学上高质量的研究中也是如此。与大多数兽医学和医学领域一样,还需要进一步开展良好/优秀的研究。按照顺势疗法的原则,下一步合理的举措是开展更多聚焦于顺势疗法治疗感染的方法学高质量试验。由经过适当培训的顺势疗法医生/兽医选择恰当的相似物(个体化适配的顺势疗法药品)对于顺势疗法的有效性至关重要。在大学机构开展研究是质量保证的前提条件。因此,为了患者的最大利益,顺势疗法在大学中的进一步整合是必要的要求。